America’s ‘Psychedelic Spring’—Why Are These Drugs Growing in Cultural Importance Again?

‘In the past few years, LSD, mushrooms, ketamine and MDMA are coming out of the closet, with researchers studying these substances as potential treatments for anxiety, depression, PTSD and addiction. It’s exciting research and it’s taking off for the first time since 1970, when Richard Nixon signed the Controlled Substances Act into law.
The law classified hallucinogenic substances like LSD, DMT, psilocybin (the psychedelic alkaloid in mushrooms) and mescaline as Schedule I substances—the most restrictive category, reserved for drugs with “high potential for abuse and no accepted medical use.” Although there are still research bans on the drugs, scientists are getting creative about obtaining funding, while governments are facing increasing pressure to allow medical research on psychedelic substances.’
Read more: America’s ‘Psychedelic Spring’—Why Are These Drugs Growing in Cultural Importance Again?